North America Cancer Treatment Drugs Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Info Research
120 Pages
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.


Scope of the Report:
This report focuses on the Cancer Treatment Drugs in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
Bristol-Myers Squibb
Takeda
Eli Lilly
Pfizer
AstraZeneca
Astellas
Sanofi
Bayer
Merck & Co.
Biogen Idec
Kyowa Hakko Kirin
Otsuka
Teva
Eisai
Merck KGaA
Ipsen
AbbVie
Gilead Sciences

Market Segment by Countries, covering
United States
Canada
Mexico

Market Segment by Type, covers
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others

Market Segment by Applications, can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers

There are 15 Chapters to deeply display the North America Cancer Treatment Drugs market.

Chapter 1, to describe Cancer Treatment Drugs Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Cancer Treatment Drugs, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Cancer Treatment Drugs, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Cancer Treatment Drugs market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Cancer Treatment Drugs Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents

1 Market Overview

1.1 Cancer Treatment Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Chemotherapy

1.2.2 Targeted Therapy

1.2.3 Immunotherapy (Biologic Therapy)

1.2.4 Hormonal Therapy

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Blood Cancer

1.3.2 Breast Cancer

1.3.3 Gastrointestinal Cancer

1.3.4 Prostate Cancer

1.3.5 Respiratory/Lung Cancer

1.3.6 Other Cancers

1.4 Market Analysis by Countries

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 Mexico Status and Prospect (2012-2022)

1.4.3 Canada Status and Prospect (2012-2022)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Roche

2.1.1 Profile

2.1.2 Cancer Treatment Drugs Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.4 Business Overview

2.1.5 Roche News

2.2 Novartis

2.2.1 Profile

2.2.2 Cancer Treatment Drugs Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.4 Business Overview

2.2.5 Novartis News

2.3 Celgene

2.3.1 Profile

2.3.2 Cancer Treatment Drugs Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.4 Business Overview

2.3.5 Celgene News

2.4 Amgen

2.4.1 Profile

2.4.2 Cancer Treatment Drugs Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.4 Business Overview

2.4.5 Amgen News

2.5 Johnson & Johnson

2.5.1 Profile

2.5.2 Cancer Treatment Drugs Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5.4 Business Overview

2.5.5 Johnson & Johnson News

2.6 Bristol-Myers Squibb

2.6.1 Profile

2.6.2 Cancer Treatment Drugs Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6.4 Business Overview

2.6.5 Bristol-Myers Squibb News

2.7 Takeda

2.7.1 Profile

2.7.2 Cancer Treatment Drugs Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7.4 Business Overview

2.7.5 Takeda News

2.8 Eli Lilly

2.8.1 Profile

2.8.2 Cancer Treatment Drugs Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8.4 Business Overview

2.8.5 Eli Lilly News

2.9 Pfizer

2.9.1 Profile

2.9.2 Cancer Treatment Drugs Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9.4 Business Overview

2.9.5 Pfizer News

2.10 AstraZeneca

2.10.1 Profile

2.10.2 Cancer Treatment Drugs Type and Applications

2.10.2.1 Type 1

2.10.2.2 Type 2

2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10.4 Business Overview

2.10.5 AstraZeneca News

2.11 Astellas

2.11.1 Profile

2.11.2 Cancer Treatment Drugs Type and Applications

2.11.2.1 Type 1

2.11.2.2 Type 2

2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11.4 Business Overview

2.11.5 Astellas News

2.12 Sanofi

2.12.1 Profile

2.12.2 Cancer Treatment Drugs Type and Applications

2.12.2.1 Type 1

2.12.2.2 Type 2

2.12.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12.4 Business Overview

2.12.5 Sanofi News

2.13 Bayer

2.13.1 Profile

2.13.2 Cancer Treatment Drugs Type and Applications

2.13.2.1 Type 1

2.13.2.2 Type 2

2.13.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13.4 Business Overview

2.13.5 Bayer News

2.14 Merck & Co.

2.14.1 Profile

2.14.2 Cancer Treatment Drugs Type and Applications

2.14.2.1 Type 1

2.14.2.2 Type 2

2.14.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14.4 Business Overview

2.14.5 Merck & Co. News

2.15 Biogen Idec

2.15.1 Profile

2.15.2 Cancer Treatment Drugs Type and Applications

2.15.2.1 Type 1

.2.2 Type 2

2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15.4 Business Overview

2.15.5 Biogen Idec News

2.16 Kyowa Hakko Kirin

2.16.1 Profile

2.16.2 Cancer Treatment Drugs Type and Applications

2.16.2.1 Type 1

2.16.2.2 Type 2

2.16.3 Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16.4 Business Overview

2.16.5 Kyowa Hakko Kirin News

2.17 Otsuka

2.17.1 Profile

2.17.2 Cancer Treatment Drugs Type and Applications

2.17.2.1 Type 1

2.17.2.2 Type 2

2.17.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17.4 Business Overview

2.17.5 Otsuka News

2.18 Teva

2.18.1 Profile

2.18.2 Cancer Treatment Drugs Type and Applications

2.18.2.1 Type 1

2.18.2.2 Type 2

2.18.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.18.4 Business Overview

2.18.5 Teva News

2.19 Eisai

2.19.1 Profile

2.19.2 Cancer Treatment Drugs Type and Applications

2.19.2.1 Type 1

2.19.2.2 Type 2

2.19.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.19.4 Business Overview

2.19.5 Eisai News

2.20 Merck KGaA

2.20.1 Profile

2.20.2 Cancer Treatment Drugs Type and Applications

2.20.2.1 Type 1

2.20.2.2 Type 2

2.20.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.20.4 Business Overview

2.20.5 Merck KGaA News

2.21 Ipsen

2.21.1 Profile

2.21.2 Cancer Treatment Drugs Type and Applications

2.21.2.1 Type 1

2.21.2.2 Type 2

2.21.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.21.4 Business Overview

2.21.5 Ipsen News

2.22 AbbVie

2.22.1 Profile

2.22.2 Cancer Treatment Drugs Type and Applications

2.22.2.1 Type 1

2.22.2.2 Type 2

2.22.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.22.4 Business Overview

2.22.5 AbbVie News

2.23 Gilead Sciences

2.23.1 Profile

2.23.2 Cancer Treatment Drugs Type and Applications

2.23.2.1 Type 1

2.23.2.2 Type 2

2.23.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.23.4 Business Overview

2.23.5 Gilead Sciences News

3 North America Cancer Treatment Drugs Market Competition, by Manufacturer

3.1 North America Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 North America Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 North America Cancer Treatment Drugs Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share

3.4.2 Top 5 Cancer Treatment Drugs Manufacturer Market Share

3.5 Market Competition Trend

4 North America Cancer Treatment Drugs Market Analysis by Countries

4.1 North America Cancer Treatment Drugs Sales Market Share by Countries

4.2 North America Cancer Treatment Drugs Sales by Countries (2012-2017)

4.3 North America Cancer Treatment Drugs Revenue (Value) by Countries (2012-2017)

5 North America Market Segmentation Cancer Treatment Drugs by Type

5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2012-2017)

5.1.1 North America Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)

5.1.2 North America Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)

5.2 Chemotherapy Sales Growth and Price

5.2.1 North America Chemotherapy Sales Growth (2012-2017)

5.2.2 North America Chemotherapy Price (2012-2017)

5.3 Targeted Therapy Sales Growth and Price

5.3.1 North America Targeted Therapy Sales Growth (2012-2017)

5.3.2 North America Targeted Therapy Price (2012-2017)

5.4 Immunotherapy (Biologic Therapy) Sales Growth and Price

5.4.1 North America Immunotherapy (Biologic Therapy) Sales Growth (2012-2017)

5.4.2 North America Immunotherapy (Biologic Therapy) Price (2012-2017)

5.5 Hormonal Therapy Sales Growth and Price

5.5.1 North America Hormonal Therapy Sales Growth (2012-2017)

5.5.2 North America Hormonal Therapy Price (2012-2017)

5.6 Others Sales Growth and Price

5.6.1 North America Others Sales Growth (2012-2017)

5.6.2 North America Others Price (2012-2017)

6 North America Market Segmentation Cancer Treatment Drugs by Application

6.1 North America Cancer Treatment Drugs Sales Market Share by Application (2012-2017)

6.2 Blood Cancer Sales Growth (2012-2017)

6.3 Breast Cancer Sales Growth (2012-2017)

6.4 Gastrointestinal Cancer Sales Growth (2012-2017)

6.5 Prostate Cancer Sales Growth (2012-2017)

6.6 Respiratory/Lung Cancer Sales Growth (2012-2017)

6.7 Other Cancers Sales Growth (2012-2017)

7 United States Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers

7.1 United States Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)

7.2 United States Cancer Treatment Drugs Sales and Market Share by Type

7.3 United States Cancer Treatment Drugs Sales by Application (2012-2017)

7.4 United States Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer

7.4.1 United States Cancer Treatment Drugs Sales and Market Share by Manufacturer

7.4.2 United States Cancer Treatment Drugs Revenue and Market Share by Manufacturer

7.5 United States Cancer Treatment Drugs Export and Import (2012-2017)

8 Canada Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers

8.1 Canada Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)

8.2 Canada Cancer Treatment Drugs Sales and Market Share by Type

8.3 Canada Cancer Treatment Drugs Sales by Application (2012-2017)

8.4 Canada Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer

8.4.1 Canada Cancer Treatment Drugs Sales and Market Share by Manufacturer

8.4.2 Canada Cancer Treatment Drugs Revenue and Market Share by Manufacturer

8.5 Canada Cancer Treatment Drugs Export and Import (2012-2017)

9 Mexico Cancer Treatment Drugs Sales, Revenue, by Type, Application and Manufacturers

9.1 Mexico Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)

9.2 Mexico Cancer Treatment Drugs Sales and Market Share by Type

9.3 Mexico Cancer Treatment Drugs Sales by Application (2012-2017)

9.4 Mexico Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer

9.4.1 Mexico Cancer Treatment Drugs Sales and Market Share by Manufacturer

9.4.2 Mexico Cancer Treatment Drugs Revenue and Market Share by Manufacturer

9.5 Mexico Cancer Treatment Drugs Export and Import (2012-2017)

10 Cancer Treatment Drugs Market Forecast (2017-2022)

10.1 North America Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)

10.2 Cancer Treatment Drugs Market Forecast by Countries (2017-2022)

10.2.1 United States Cancer Treatment Drugs Forecast (2017-2022)

10.2.2 Canada Cancer Treatment Drugs Forecast (2017-2022)

10.2.3 Mexico Cancer Treatment Drugs Forecast (2017-2022)

10.3 Cancer Treatment Drugs Market Forecast by Type (2017-2022)

10.4 Cancer Treatment Drugs Market Forecast by Application (2017-2022)

11 Cancer Treatment Drugs Manufacturing Cost Analysis

11.1 Cancer Treatment Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Cancer Treatment Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Cancer Treatment Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016

12.4 Downstream Buyers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Analyst Introduction

15.3 Data Source


List of Tables and Figures



Figure Cancer Treatment Drugs Picture

Table Product Specifications of Cancer Treatment Drugs

Figure North America Sales Market Share of Cancer Treatment Drugs by Types in 2016

Table Types of Cancer Treatment Drugs

Figure Chemotherapy Picture

Table Major Manufacturers of Chemotherapy

Figure Targeted Therapy Picture

Table Major Manufacturers of Targeted Therapy

Figure Immunotherapy (Biologic Therapy) Picture

Table Major Manufacturers of Immunotherapy (Biologic Therapy)

Figure Hormonal Therapy Picture

Table Major Manufacturers of Hormonal Therapy

Figure Others Picture

Table Major Manufacturers of Others

Table North America Cancer Treatment Drugs Sales Market Share by Applications in 2016

Table Applications of Cancer Treatment Drugs

Figure Blood Cancer Picture

Figure Breast Cancer Picture

Figure Gastrointestinal Cancer Picture

Figure Prostate Cancer Picture

Figure Respiratory/Lung Cancer Picture

Figure Other Cancers Picture

Figure United States Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Mexico Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Canada Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Table Roche Basic Information, Manufacturing Base and Competitors

Table Roche Cancer Treatment Drugs Type and Applications

Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Cancer Treatment Drugs Type and Applications

Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Celgene Basic Information, Manufacturing Base and Competitors

Table Celgene Cancer Treatment Drugs Type and Applications

Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Cancer Treatment Drugs Type and Applications

Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Cancer Treatment Drugs Type and Applications

Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications

Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Takeda Basic Information, Manufacturing Base and Competitors

Table Takeda Cancer Treatment Drugs Type and Applications

Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Cancer Treatment Drugs Type and Applications

Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Cancer Treatment Drugs Type and Applications

Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Cancer Treatment Drugs Type and Applications

Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Astellas Basic Information, Manufacturing Base and Competitors

Table Astellas Cancer Treatment Drugs Type and Applications

Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Cancer Treatment Drugs Type and Applications

Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Cancer Treatment Drugs Type and Applications

Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck & Co. Basic Information, Manufacturing Base and Competitors

Table Merck & Co. Cancer Treatment Drugs Type and Applications

Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biogen Idec Basic Information, Manufacturing Base and Competitors

Table Biogen Idec Cancer Treatment Drugs Type and Applications

Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors

Table Kyowa Hakko Kirin Cancer Treatment Drugs Type and Applications

Table Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Otsuka Basic Information, Manufacturing Base and Competitors

Table Otsuka Cancer Treatment Drugs Type and Applications

Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Cancer Treatment Drugs Type and Applications

Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eisai Basic Information, Manufacturing Base and Competitors

Table Eisai Cancer Treatment Drugs Type and Applications

Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck KGaA Basic Information, Manufacturing Base and Competitors

Table Merck KGaA Cancer Treatment Drugs Type and Applications

Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Ipsen Basic Information, Manufacturing Base and Competitors

Table Ipsen Cancer Treatment Drugs Type and Applications

Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Cancer Treatment Drugs Type and Applications

Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Gilead Sciences Basic Information, Manufacturing Base and Competitors

Table Gilead Sciences Cancer Treatment Drugs Type and Applications

Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table North America Cancer Treatment Drugs Sales by Manufacturer (2016-2017)

Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016

Figure North America Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017

Table North America Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)

Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016

Figure North America Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017

Table North America Cancer Treatment Drugs Price by Manufacturers (2016-2017)

Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2016

Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2017

Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2016

Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2017

Figure North America Cancer Treatment Drugs Sales and Growth (2012-2017)

Table North America Cancer Treatment Drugs Sales by Countries (2012-2017)

Table North America Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)

Figure North America 2012 Cancer Treatment Drugs Sales Market Share by Countries

Figure North America 2016 Cancer Treatment Drugs Sales Market Share by Countries

Figure North America Cancer Treatment Drugs Revenue and Growth (2012-2017)

Table North America Cancer Treatment Drugs Revenue by Countries (2012-2017)

Table North America Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)

Table North America 2012 Cancer Treatment Drugs Revenue Market Share by Countries

Table North America 2016 Cancer Treatment Drugs Revenue Market Share by Countries

Table North America Cancer Treatment Drugs Sales by Type (2012-2017)

Table North America Cancer Treatment Drugs Sales Share by Type (2012-2017)

Table North America Cancer Treatment Drugs Revenue by Type (2012-2017)

Table North America Cancer Treatment Drugs Revenue Share by Type (2012-2017)

Figure North America Chemotherapy Sales Growth (2012-2017)

Figure North America Chemotherapy Price (2012-2017)

Figure North America Targeted Therapy Sales Growth (2012-2017)

Figure North America Targeted Therapy Price (2012-2017)

Figure North America Immunotherapy (Biologic Therapy) Sales Growth (2012-2017)

Figure North America Immunotherapy (Biologic Therapy) Price (2012-2017)

Figure North America Hormonal Therapy Sales Growth (2012-2017)

Figure North America Hormonal Therapy Price (2012-2017)

Figure North America Others Sales Growth (2012-2017)

Figure North America Others Price (2012-2017)

Table North America Cancer Treatment Drugs Sales by Application (2012-2017)

Table North America Cancer Treatment Drugs Sales Share by Application (2012-2017)

Figure North America Blood Cancer Sales Growth (2012-2017)

Figure North America Breast Cancer Sales Growth (2012-2017)

Figure North America Gastrointestinal Cancer Sales Growth (2012-2017)

Figure North America Prostate Cancer Sales Growth (2012-2017)

Figure North America Respiratory/Lung Cancer Sales Growth (2012-2017)

Figure North America Other Cancers Sales Growth (2012-2017)

Figure United States Cancer Treatment Drugs Revenue and Growth (2012-2017)

Figure United States Cancer Treatment Drugs Sales and Growth (2012-2017)

Table United States Cancer Treatment Drugs Sales by Type (2012-2017)

Table United States Cancer Treatment Drugs Sales Market Share by Type (2012-2017)

Table United States Cancer Treatment Drugs Sales by Application (2012-2017)

Table United States Cancer Treatment Drugs Sales Market Share by Application (2012-2017)

Table United States Cancer Treatment Drugs Sales by Manufacturer (2016-2017)

Figure United States Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016

Figure United States Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017

Table United States Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)

Figure United States Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016

Figure United States Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017

Table United States Cancer Treatment Drugs Export and Import (2012-2017)

Figure Canada Cancer Treatment Drugs Revenue and Growth (2012-2017)

Figure Canada Cancer Treatment Drugs Sales and Growth (2012-2017)

Table Canada Cancer Treatment Drugs Sales by Type (2012-2017)

Table Canada Cancer Treatment Drugs Sales Market Share by Type (2012-2017)

Table Canada Cancer Treatment Drugs Sales by Application (2012-2017)

Table Canada Cancer Treatment Drugs Sales Market Share by Application (2012-2017)

Table Canada Cancer Treatment Drugs Sales by Manufacturer (2016-2017)

Figure Canada Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016

Figure Canada Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017

Table Canada Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)

Figure Canada Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016

Figure Canada Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017

Table Canada Cancer Treatment Drugs Export and Import (2012-2017)

Figure Mexico Cancer Treatment Drugs Revenue and Growth (2012-2017)

Figure Mexico Cancer Treatment Drugs Sales and Growth (2012-2017)

Table Mexico Cancer Treatment Drugs Sales by Type (2012-2017)

Table Mexico Cancer Treatment Drugs Sales Market Share by Type (2012-2017)

Table Mexico Cancer Treatment Drugs Sales by Application (2012-2017)

Table Mexico Cancer Treatment Drugs Sales Market Share by Application (2012-2017)

Table Mexico Cancer Treatment Drugs Sales by Manufacturer (2016-2017)

Figure Mexico Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016

Figure Mexico Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017

Table Mexico Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)

Figure Mexico Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016

Figure Mexico Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017

Table Mexico Cancer Treatment Drugs Export and Import (2012-2017)

Figure North America Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)

Table North America Cancer Treatment Drugs Sales Forecast by Countries (2017-2022)

Table North America Cancer Treatment Drugs Market Share Forecast by Countries (2017-2022)

Figure United States Cancer Treatment Drugs Sales Forecast (2017-2022)

Figure Canada Cancer Treatment Drugs Sales Forecast (2017-2022)

Figure Mexico Cancer Treatment Drugs Sales Forecast (2017-2022)

Table North America Cancer Treatment Drugs Sales Forecast by Type (2017-2022)

Table North America Cancer Treatment Drugs Market Share Forecast by Type (2017-2022)

Table North America Cancer Treatment Drugs Sales Forecast by Application (2017-2022)

Table North America Cancer Treatment Drugs Market Share Forecast by Application (2017-2022)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cancer Treatment Drugs

Figure Manufacturing Process Analysis of Cancer Treatment Drugs

Figure Cancer Treatment Drugs Industrial Chain Analysis

Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016

Table Major Buyers of Cancer Treatment Drugs

Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

United States Paints & Coatings Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-12-15 Chemical & Materials

Paint is defined as a paints material in liquid or solid which when spread on a surface adheres and ...Read More

United States Fire Alarm Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-12-15 Chemical & Materials

A fire alarm system has a number of devices working together to detect and warn people through visua...Read More

North America Sandalwood Oil Market by Manufacturers, Countries, Type and Application, Forecast to 2022

GIR 2017-12-15 Chemical & Materials

Sandalwood, of the genus Santalum, is a genus of woody flowering trees and plants. Most species are ...Read More

Report's License Type

$4480
$8960

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.